Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ian Mortimer
30 Sep 2026
President & CEO
Buy
30,000
$37.38
$1.12M
Thomas Patrick Kelly
30 Sep 2026
Chief Financial Officer
Buy
15,000
$37.32
$559.74K
Christopher John Kenney
21 Jan 2022
Chief Medical Officer
Buy
700
$28.81
$20.17K
Seggern Christopher Von
6 Dec 2021
Chief Commercial Officer
Buy
4,000
$24.40
$97.60K
Mohammad Azab
15 Nov 2017
Director
Buy
15,000
$2.22
$33.28K
Mohammad Azab
22 Sep 2017
Director
Buy
8,000
$2.95
$23.60K
Mohammad Azab
21 Sep 2017
Director
Buy
2,000
$2.95
$5.90K
Raymond Winquist
18 Aug 2017
Head, Translational Research
Buy
1,000
$3.00
$3.00K
Mohammad Azab
18 Aug 2017
Director
Buy
6,312
$2.90
$18.30K
Mohammad Azab
17 Aug 2017
Director
Buy
23
$2.65
$60.95
Bvf Partners L P/Il
15 Aug 2017
10% owner
Buy
7,429
$2.41
$17.92K
Bvf Partners L P/Il
15 Aug 2017
10% owner
Buy
11,429
$2.41
$27.57K
James R. Empfield
15 Aug 2017
SVP, Drug Discovery
Buy
10,000
$2.48
$24.82K
Michael R Hayden
14 Aug 2017
Director
Buy
15,000
$2.75
$41.25K
Dawn Svoronos
14 Aug 2017
Director
Buy
50,000
$2.82
$140.77K
Bvf Partners L P/Il
14 Aug 2017
10% owner
Buy
13,337
$2.70
$36.06K
Bvf Partners L P/Il
14 Aug 2017
10% owner
Buy
28,007
$2.70
$75.72K
Steven Gannon
11 Aug 2017
Director
Buy
15,000
$2.82
$42.27K
Simon N. Pimstone
10 Aug 2017
President & CEO
Buy
6,000
$2.90
$17.40K
Richard H Scheller
10 Aug 2017
Director
Buy
7,000
$2.85
$19.95K
Ian Mortimer
10 Aug 2017
CFO & COO
Buy indirect
10,000
$2.90
$29.00K
Ian Mortimer
10 Aug 2017
CFO & COO
Buy
5,000
$2.85
$14.23K
Gary Patou
10 Aug 2017
Director
Buy indirect
7,500
$2.78
$20.84K
Gary Patou
8 Aug 2017
Director
Buy indirect
5,000
$3.00
$15.00K
Bvf Partners L P/Il
27 Jun 2017
10% owner
Buy
8,496
$4.00
$33.98K
Bvf Partners L P/Il
27 Jun 2017
10% owner
Buy
30,170
$4.00
$120.68K
Bvf Partners L P/Il
27 Jun 2017
10% owner
Buy
46,795
$4.00
$187.18K
Bvf Partners L P/Il
22 Jun 2017
10% owner
Buy
854
$4.00
$3.42K
Bvf Partners L P/Il
22 Jun 2017
10% owner
Buy
2,884
$4.00
$11.54K
Bvf Partners L P/Il
22 Jun 2017
10% owner
Buy
4,525
$4.00
$18.10K
Bvf Partners L P/Il
21 Jun 2017
10% owner
Buy
1,362
$4.00
$5.45K
Bvf Partners L P/Il
21 Jun 2017
10% owner
Buy
4,406
$4.00
$17.62K
Bvf Partners L P/Il
21 Jun 2017
10% owner
Buy
6,380
$4.00
$25.52K
Bvf Partners L P/Il
19 Jun 2017
10% owner
Buy
357
$3.85
$1.37K
Bvf Partners L P/Il
19 Jun 2017
10% owner
Buy
1,271
$3.85
$4.89K
Bvf Partners L P/Il
19 Jun 2017
10% owner
Buy
1,967
$3.85
$7.57K
Bvf Partners L P/Il
16 Jun 2017
10% owner
Buy
1,064
$3.85
$4.10K
Bvf Partners L P/Il
16 Jun 2017
10% owner
Buy
3,873
$3.85
$14.91K
Bvf Partners L P/Il
16 Jun 2017
10% owner
Buy
6,097
$3.85
$23.47K
Bvf Partners L P/Il
15 Jun 2017
10% owner
Buy
1,160
$3.84
$4.45K
Bvf Partners L P/Il
15 Jun 2017
10% owner
Buy
3,845
$3.84
$14.75K
Bvf Partners L P/Il
15 Jun 2017
10% owner
Buy
6,774
$3.84
$25.99K
Bvf Partners L P/Il
7 Jun 2017
10% owner
Buy
20,594
$3.85
$79.31K
Bvf Partners L P/Il
7 Jun 2017
10% owner
Buy
73,749
$3.85
$284.02K
Bvf Partners L P/Il
7 Jun 2017
10% owner
Buy
113,446
$3.85
$436.90K
Bvf Partners L P/Il
6 Jun 2017
10% owner
Buy
913
$3.75
$3.42K
Bvf Partners L P/Il
6 Jun 2017
10% owner
Buy
53,260
$3.75
$199.73K
Bvf Partners L P/Il
6 Jun 2017
10% owner
Buy
96,736
$3.75
$362.76K

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 64
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 4,426,192
Sales filed before the plan box existed 23
History held since 6 Nov 2014